share_log

华东医药:浙江天册律师事务所关于华东医药股份有限公司2022年限制性股票激励计划调整限制性股票回购价格及回购注销部分限制性股票之法律意见书

Huadong Medicine: Legal Opinion of Zhejiang Tianze Law Firm on Huadong Pharmaceutical Co., Ltd.'s 2022 Restricted Stock Incentive Plan to Adjust Restricted Stock Repurchase Prices and Repurchase and Cancellation of Some Restricted Shares

Sensex a share ·  May 30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more